Αποτελέσματα Αναζήτησης
4 Οκτ 2022 · General issues related to antimicrobial resistance and treatment of CoNS infections will be reviewed here. Issues related to treatment of Staphylococcus lugdunensis are discussed separately. (See "Staphylococcus lugdunensis" .)
- Infection due to coagulase-negative staphylococci ... - UpToDate
Coagulase-negative staphylococci (CoNS) are among the most...
- Infection due to coagulase-negative staphylococci ... - UpToDate
16 Φεβ 2024 · Antibiotic resistance is a serious treatment-related complication of CoNS. Coagulase-negative staphylococci often are resistant to oxacillin/methicillin, penicillin, ciprofloxacin, gentamicin, erythromycin, and clindamycin, which requires the use of second-line antibiotics such as linezolid, vancomycin, or daptomycin. 10 While the optimal ...
9 Μαρ 2018 · Because CoNS infections are traditionally hard to treat, it’s important that a person see a doctor as early as possible. Early treatment will prevent the bacteria from continuing to multiply.
4 Ιουν 2020 · The definition of CoNS as a heterogeneous group of staphylococci is based on diagnostic procedures that fulfil the clinical need to differentiate between Staphylococcus aureus, commonly known as strongly pathogenic, and other staphylococci classified as non- or less pathogenic [7].
29 Αυγ 2022 · Coagulase-negative staphylococci (CoNS) are among the most frequent constituents of normal skin flora [1,2]. These organisms are increasingly recognized as agents of clinically significant infection, including bacteremia and endocarditis [3].
4 Οκτ 2022 · General discussions related to the diagnosis and treatment of infective endocarditis and to the epidemiology, microbiology, pathogenesis, and antibiotic resistance patterns of CoNS are presented separately.
Coagulase-negative staphylococci (CoNS) are recognized as comprising the main part of human normal microbiota and are rarely associated with severe and intensive infections. However, these organisms can cause a number of infections in humans, especially immunocompromised patients and neonates.
